AIDOT Showcases AI-Based Cervical Cancer Diagnostic Solution ‘Cerviray AI’ at 2025 Korean Society of Gynecologic Oncology Training Course (August 19, 2025)

AIDOT, a leading company in AI-based medical solutions, announced that it presented its cervical cancer diagnostic AI solution, Cerviray AI, at the training course hosted by the 2025 Korean Society of Gynecologic Oncology, held at Korea University College of Medicine’s Department of Obstetrics and Gynecology.

The training course took place on August 17, 2025, at Yookwangsa Hall, Korea University Anam Hospital, providing obstetrics, gynecology, and gynecologic oncology professionals with an opportunity to share the latest clinical insights and innovative diagnostic technologies.

At the event, AIDOT demonstrated the clinical application of Cerviray AI and conducted real-time demonstrations, showcasing the accuracy and efficiency of AI-assisted automatic cervical image interpretation to attending medical professionals.

Notably, Cerviray AI has recently been adopted by numerous hospitals in Korea and abroad, helping reduce diagnostic time for clinicians and providing more consistent results, earning recognition for driving a paradigm shift in gynecologic diagnostics.

AIDOT CEO Jaehun Jung said,
“Participating in this training course provided an important opportunity to establish closer collaboration with obstetrics and gynecologic oncology professionals, while actively demonstrating the real-world clinical benefits of AI-based cervical cancer diagnostics.”

Cerviray AI integrates AI into traditional visual inspection with acetic acid (VIA), supporting rapid and precise interpretation. AIDOT plans to continue promoting medical innovation through participation in domestic and international conferences and hands-on educational programs.

Korea Economic TV / August 19, 2025 / Deputy Director Jaejun Yang